| dc.contributor.author | Mellanby, Richard J. | |
| dc.contributor.author | Scott, Jamie I. | |
| dc.contributor.author | Mair, Iris | |
| dc.contributor.author | Fernández Vargas, Antonio Jesús | |
| dc.contributor.author | Saul, Louise | |
| dc.contributor.author | Arlt, Jochen | |
| dc.contributor.author | Moral, Mónica | |
| dc.contributor.author | Vendrell, Marc | |
| dc.date.accessioned | 2025-01-09T11:14:15Z | |
| dc.date.available | 2025-01-09T11:14:15Z | |
| dc.date.issued | 2018-07-30 | |
| dc.identifier.citation | Chem. Sci., 2018,9, 7261-7270 | es_ES |
| dc.identifier.uri | https://hdl.handle.net/10481/98764 | |
| dc.description.abstract | Herein tricarbocyanine N-triazoles are first described as a rationally-designed near-infrared (NIR) structure
overcoming the brightness and photostability limitations of tricarbocyanines for long-term in vivo imaging.
The straightforward synthetic approach and the wide availability of alkynes makes this strategy a versatile
methodology for the preparation of highly stable N-substituted tricarbocyanines. Furthermore, we validated
CIR38M as a non-transferable marker to monitor the fate of therapeutic T cells non-invasively in vivo,
showing enhanced performance over conventional NIR fluorophores (i.e. DiR, IR800CW and indocyanine
green) as well as compatibility with human cells for translational studies. CIR38M is able to track over time
smaller numbers of T cells than current NIR agents, and to visualise antigen-driven accumulation of
immune cells at specific sites in vivo. This chemical technology will improve longitudinal imaging studies to
assess the efficacy of cell-based immunotherapies in preclinical models and in human samples. | es_ES |
| dc.description.sponsorship | Wellcome Trust Intermediate
Clinical Fellowship (098493/Z/12/Z) | es_ES |
| dc.description.sponsorship | MSCA
Individual Fellowship (704912) | es_ES |
| dc.description.sponsorship | Foundation
Alfonso Martin Escudero (FAME, Spain) | es_ES |
| dc.description.sponsorship | EPSRC and MRC Centre for Doctoral Training
in Optical Medical Imaging OPTIMA (EP/L016559/1) | es_ES |
| dc.description.sponsorship | Scottish
Funding Council (H14052) | es_ES |
| dc.description.sponsorship | Biotechnology and Biological Sciences Research Council (BB/
M025160/1), | es_ES |
| dc.description.sponsorship | The Royal Society (RG160289) | es_ES |
| dc.description.sponsorship | ERC
Consolidator Grant (771443) | es_ES |
| dc.description.sponsorship | Marie Curie Integration Grant (333847) | es_ES |
| dc.language.iso | eng | es_ES |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.title | Tricarbocyanine N-triazoles: the scaffold-ofchoice for long-term near-infrared imaging of immune cells in vivo | es_ES |
| dc.type | journal article | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.identifier.doi | 10.1039/c8sc00900g | |